821 results about "Medication taking" patented technology

The drug compliance monitoring system provides a patient with a portable medication dispenser programmed with medication-taking data. The dispenser alerts the patient to take a dose of medication and gathers compliance data relating to the medication-taking data. The compliance data is accessible to a physician, or other caregiver, etc., via a network database.

A medication-taking confirmation support device includes a pill case having a pill housing section, an electronic clock equipped with a memory, a notification unit and a controller, a pill case open/close sensor, and a reconfirmation signal input device. The controller makes the notification unit notify a medication-taking confirmation time on the basis of a detection signal from the pill case open/close sensor and also makes the memory store the medication-taking confirmation time at the time of taking medication. The controller further makes the notification unit re-notify the medication-taking confirmation time read out from the memory on the basis of a signal from the reconfirmation signal input device after having taken medication.

The invention relates to an intelligent medicine box system. The intelligent medicine box system comprises a plurality of intelligent medicine boxes, a plurality of user terminals, a plurality of background management terminals, a cloud server and intelligent medicine box management software, wherein the intelligent medicine boxes are connected with the user terminals; the intelligent medicine boxes are connected with the cloud server; the cloud server is connected with the background management terminals and a database respectively; a plurality of functional modules are arranged in the intelligent medicine boxes; each functional module realizes the function thereof by virtue of the intelligent medicine box management software. The intelligent medicine box system provided by the invention is capable of realizing the functions of reminding a patient to take medicine on time, automatically recording a medicine-taking event and the like, is also capable of providing knowledge in the aspects of diseases, medicine curative effects, medicine safety and the like for the patient, thus fundamentally the compliance of the patient, and is further capable of helping the patient to actively record medicine-taking compliance data, and acquiring the medicine-taking experience data of the patient. The intelligent medicine boxes are capable of storing medicines according to the dosage of one week, and capable of adjusting the storage mode according to daily medicine-taking times, thus facilitating management.

A prescription compliance device which aids patients in complying with instructions given by a physician for taking prescription medication. The device reminds a patient when the next dose of medication is to be taken and indicates whether a specified dose has been taken. The device includes a microcontroller, a display, a program memory for storing pre-programmed medication-taking regimens for single and multiple medications, a real time clock, a selector for selecting one of the regimens and for programming the device as to the time and day on which a first dose of medication is to be taken, a display which alternately displays the current time and a time at which a next dose of medication is to be taken and an alarm which alerts the patient at times when a dose of medication is to de taken. The selector includes an event switch which is activated by the patient after taking a dose of medication so as to record the taking of medication and to cause the microcontroller to effect the display of the next time at which a dose of medication is to be taken. A memory may also be included to record the times at which a patient takes doses of medication. The device also includes a remote programming feature via a wireless link.

The oral cavity quick dissolving and quick disintegrating freeze dried tablet for children includes at least one medicinal active component and at least one medicinal stuffing, adhesive and other supplementary material. It is loose and porous tablet in network structure and prepared through common freeze drying process. The said medicinal active component may be different children's medicines, such as antibiotic, antipyretic, analgesic, cough stopping and phlegm eliminating medicine, cold medicine, etc. Bitter or excitant medicine may be coated and water insoluble medicine is prepared intofine powder of 50 micron below size for stable dispersion in liquid. The present invention has fast disintegration, no jamming in throat, simple preparation process and low cost.

The invention belongs to the technical field of wireless communication, and particularly relates to an intelligent medical service system based on RFID (radio frequency identification devices) and CDM (code division multiplex) technologies, which comprises a sensor data acquisition layer, a medical resource management layer and an intelligent medical service provision layer. Different modules of the sensor data acquisition layer are integrated inside an intelligent medicine kit to serve as a household intelligent terminal which is combined with the RFID sensor technology and the CDM material technology and supports various sensor networks, the wireless network and 3G (generation)/4G networks. Besides, one end of the intelligent terminal is connected with the intelligent medical service provision layer which serves as the upper layer, and the other end of the intelligent terminal carries out private self-services including dosing reminding and recording, intelligent drug package control, sign parameter acquisition recording, emergency alarming and remote acquisition of doctor suggestions. The intelligent medical service system is capable of changing the 'hospital-centered and doctor-centered' nursing mode into the 'household-centered and patient-centered' nursing mode, and accordingly self-nursing efficiency and reliability of patients are improved remarkably and medical resources are saved greatly.

The invention discloses an intelligent electronic medical kit, which comprises an electronic control module and a medicine box body, wherein the electronic control module comprises a control unit and a medicine box switching detection control unit; wherein the medicine box switching detection control unit is used for detecting a switching signal of the medicine box body; the control unit stores the medicine information and the time for taking medicine, and forms a record indicating whether the medicine is taken in time according to the switching signal provided by the medicine box switching detection control unit. The intelligent electronic medical kit has the functions of medicine recording and medicine taking reminding. In addition, the invention also has the functions of local and wireless setting and alarm reminding because an output unit and a communication unit module are further arranged.

A medication reminder and compliance system including a pill box, a pill box and electronic device; or a pill box, electronic device and remote server. The pill box includes several detachable dosettes, each divided into several chambers having a door. A two-color LED is disposed beneath each chamber and is activated when a specific reminder time is reached. The LED initially illuminates the associated chamber with a green light but changes to a flashing red light if the door is not opened within a preset time. A switch engaged with the door deactivates the LED when the door is opened. The electronic device communicates with the pill box and alerts the patient when it is time to take medication. A remote server which communicates with both the pill box and electronic device can be programmed to control the reminder schedule and monitor the patient's compliance with a prescribed medication regimen.

The invention discloses slow-release microspheres coated with rivastigmine tartrate/rivastigmine for PLGA/PLA injection and a preparation method thereof. The slow-release microspheres mainly comprise rivastigmine tartrate/rivastigmine and PLGA and PLA serving as biodegradable polymer medicinal materials, and can be prepared by adopting a W1/O/W2 composite emulsified solvent volatilization method, an O/W emulsified solvent volatilization method, an O1/O2 emulsion drying method and a spray drying method. The grain diameter of the microspheres is less than 100 microns. The slow-release microspheres have high medicament loading amount, have no obvious burst release effect, can be continuously released for one week, one mouth or three mouths, are used for treating senile diseases such as Alzheimer's disease, Parkinson disease and the like, and can prolong the acting time of the medicament, reduce the application times and greatly improve the administration compliance of patients.

The invention provides an intelligent medicine taking reminding medicine box, a medicine taking reminding device and a medicine taking reminding method. The intelligent medicine taking reminding medicine box comprises a shell, a medicine disc for containing medicines, a microprocessor, a WiFi module and an alarm device; the microprocessor obtains and stores data of the medicine taking time frequencyand the medicine taking time through the WiFi module; once the medicine taking time comes, the microprocessor can give out an alarm through the alarm device to remind a patient to take medicines. According to the medicine taking reminding device and the medicine taking reminding method, the intelligent medicine taking reminding medicine box, a router and a remote server are included; and the intelligent medicine taking reminding medicine box is in networking connection with the remote server through the router. The intelligent medicine taking reminding medicine box is in wireless connection with the network through the WiFi module, a medicine list can be updated in a fully automatic manner, and manual input is not needed, so that the intelligent medicine taking reminding medicine box is intelligent, simple and convenient; meanwhile, the problems that the patient sets error time due to unskilled operation, so that wrong medicines are taken, or the patient does not set time according to prescriptions of a doctor on purpose, so that the patient does not take the medicines on time, and the medical treatment effect is poor are solved.

The invention relates to a tadalafil orally disintegrating tablet and a preparation method thereof. Aiming to improve the deficiency of existing tadalafil oral dosage forms, the invention provides the tadalafil orally disintegrating tablet which is convenient to take, is quick in absorption, takes effect quickly and has high bioavailability for doctors and patients to help the patients achieve requirements for natural and satisfactory sexual lives. The tadalafil orally disintegrating tablet takes tadalafil or medicinal salts thereof as an active ingredient, contains pharmaceutically acceptable auxiliary materials such as filling agents, disintegrating agents, flavouring agents and lubricating agents, and when being taken, dispenses with water, can be quickly disintegrated or dissolved in oral cavities only in a few seconds and is ingested along with saliva.

The invention relates to a stable vitamin C sustained release preparation and a preparation method thereof. The vitamin C sustained release preparation comprises vitamin C, an antioxidant synergist and a metal ion chelating agent. The stable vitamin C sustained release preparation has the advantages of high stability, insensitivity to change of external factors, long-acting sustained release and capabilities of uniformly, stably and gradually releasing vitamin C, the medication frequency can be reduced and bioavailability and patient compliance of the medicament can be improved. In addition, the preparation method disclosed by the invention has rational process design, is convenient to operate and is suitable for large-scale industrial production.

The invention provides a slow/controlled-release preparation of ticagrelor. The slow/controlled-release preparation of ticagrelor is an oral drug. The slow/controlled-release preparation contains ticagrelor or its pharmaceutically acceptable salt. A mass percent of ticagrelor to controlled-release accessory materials is in a range of 1: 0.2 to 1: 20 and preferably, the mass percent is in a range of 1: 0.1 to 1: 10, and a proper amount of other accessory materials are used. The slow/controlled-release base comprises one or more of cellulose, cellulose derivatives, alginate, starch, starch derivatives, polypropylene resins, carboxyvinyl polymers and other controlled-release accessory materials. Compared with a fast-release preparation, the slow/controlled-release preparation of ticagrelor provides a ticagrelor slow/controlled-release preparation system, can be eaten by a patient once each day, can change drug compliance of patients, can reduce the risk of myocardial infarction or stroke caused by acute thrombosis caused by missing of ticagrelor, and provides the easily-prepared slow/controlled-release preparation of ticagrelor or its pharmaceutically acceptable salt.

The invention belongs to the field of pharmaceutic preparations, and particularly provides a pramipexole dihydrochloride slow-release tablet with high content uniformity and a preparation method thereof. The invention provides the pramipexole dihydrochloride slow-release tablet which is independent of pH (potential of hydrogen) during drug release, is slowly released in buffer solutions with pHs of 1.2, 4.5 and 6.8 for 24 hours, reaches final release amounts above 85 percent without exception and only needs to be taken once every day. The preparation method provided by the invention is simple and practicable, relative standard deviations (RSDs) of the content uniformity and the release rate of the low-dose medicine, namely the pramipexole dihydrochloride can be guaranteed to be far below the RSD in a limit requirement, the between difference is small and the repeatability is high.

The invention discloses an Internet-based method for monitoring and personalized self-adaption nursing of a blood sugar patient. The method is characterized in that a personalized and self-adaption nursing analysis model for the blood sugar patient based on the real-time continuous monitoring of the patient's physiological data such as a blood sugar level and a blood pressure level as well as assistant data such as catering, medicine use, sports and weight is established according to technologies of cloud computing, Internet of Things, medical monitoring, intelligent terminals and the like as well as mathematical statistics principles. The method disclosed by the invention has the advantages that the blood sugar patient can master whether the blood sugar level is normal and master overall changing trends of the blood sugar level at any time and any place; the patient can know factors such as the catering, the sports or the medicine use which cause the abnormal blood sugar level at any time; and the patient can be reminded to adjust relevant life modes in time so as to control a blood sugar index to return to a normal scope. The method disclosed by the invention solves the problems that physical health gets worse because an existing patient does not know blood sugar index changes, or the changes are known by the patient and can only be found after the patient monitors scattered data or even after a medical worker makes a visit to monitor the scattered data, and overall changing trends cannot be mastered in real time.

The invention provides an intelligent auxiliary medication-taking reminding system, which comprises an image acquisition module, a voice recording and playback module, a scanning module, a display module, an information confirmation module, an alarm clock setting module, a data storage module and a data export module. The invention further provides an intelligent auxiliary medication-taking reminding method. According to the intelligent auxiliary medication-taking reminding system and the intelligent auxiliary medication-taking reminding method, a picture sticker is arranged on a medicine to serve as a medicine identity mark of the medicine, and medicine-taking dose, method and time matched with the medicine identity mark are extracted uniquely by adopting an image matching technology, thereby assisting a user in taking the medicine accurately, and being safe and reliable; historical data statistical information can be extracted and sent to an associated guardian, so that the guardiancan monitor and know the medicine-taking situation timely, thereby realizing the remote monitoring of medicine-taking situation of a patient and achieving the purposes of looking after the patient remotely.

The invention provides a memantine hydrochloride sustained release-donepezil quick release compound capsule and a preparation method thereof. The memantine hydrochloride sustained release-donepezil quick release compound capsule is characterized in that a preparation consists of memantine hydrochloride sustained release pellets and donepezil quick release granules; each sustained release pellet sequentially comprises an empty pellet core, a medicated layer and a sustained release coating layer from inside to outside; and the donepezil quick release granules are prepared from main drugs, other fillers, a disintegrating agent, adhesive and the like. Compared with other dosage forms, the preparation has the features that two drugs are combined so that a complementary synergy effect is achieved, the number of tablets can be reduced, everyday medicine taking load is reduced, and obedience and compliance of a patient can also be improved.

A computerized pill intake reminder device is disclosed. The computerized pill intake reminder device is used for storing pills, detecting the number of pills in each pouch of the blister pack, inventory management, reminding users to take their medication on time, alerting by providing an audible or a visual alarm if the medications are not taken on time and as a secondary mechanism alerting their caregiver if the user has not responded to the alert and taken the medication on time.

The device includes a top housing and a bottom housing that can be rotated about each other to form a closed and sealed module. It also includes a processor that is communicatively coupled through an electronic circuit to a plurality of electronic components housed within the pill intake reminder device. These include a speaker, microphone, infrared sensors, cameras, LED lights, microphone, RFID scanner, non-volatile memory, transmitter, and a receiver. The LED lights can be programmed with various colors.

The speaker is used to sound an audible alarm play an audible message at a specific time to remind the user to take their medication or provide an alert if the time has passed. The device also includes a pill storage module that has an upper and a lower packing plate. The space in between the plates is where the blister pack is inserted.

The device includes a pill detection module. This module includes an infrared sensor (IR) and a camera. In operation, the processor causes the infrared sensor to detect the presence of a pill inside the pouch of the pill/blister pack and the processor causes the camera to quantify the number of pills in the pouch. The pill detection is performed by using a combination of IR Sensors, photodiodes, and a light emitting mechanism. A light beam, or an array of light beams, are passed from one side of the pouch to another and the light that passes through is read by the IR sensors and used for determining whether the pouch includes pills.

The device includes a guidance system to guide the user of the pill intake reminder device to a specific pouch of the pill/blister pack for retrieving pills stored in that pouch. It does so by illuminating a light emitting diode (LED) on or around a specific pouch from which medication/pills are to be retrieved by the user. It operates by obtaining the hours of administration (HOA) schedule for the patient and then locating a pouch of the pill/blister pack that correlates with the HOA schedule. Once located, the pouch is illuminated for guidance.

The device includes a display that can be used for providing visual alerts, videos, or recorded messages for instructing the user for taking the pills.

The device uses a transmitter to send alerts to mobile phone for reminding the user to take the medication as well as sending an alert for missing or noncompliance.

The radio frequency identification (RFID) reader is used to verify that a correct pill/blister pack, the one that is associated with the user/patient is being inserted into the device. The verifying process includes scanning an RFID tag located on the blister pack and matching it to patient information.

The device also performs periodic inventory of the pills in the blister pack. This includes using an infrared sensor housed within the electronic module to determine the presence of one or more pills in the pouch and using a camera housed underneath the pouch to image and count the number of pills that are in the pouch. The inventory serves as an error check to ensure that the right number of pills from the right pouch were taken by the user at their HOA. The pill inventory system also is used to re-order more medication, if allowed by the prescription, when it detects that it is time to replenish them.

The invention relates to a sustained release tablet dosage, in particular to a Tacrolimus sustained release tablet used for liver and kidney transplantation patients and a preparation method thereof, belonging to the field of medicine technology. The invention is characterized in that Tacrolimus and adhesive are taken and dissolved in ethanol to prepare Tacrolimus solution; sustained release materials, thinner and flow agent are taken, mixed and dispersed uniformly and then added into the Tacrolimus solution to prepare wet particles, which are dried, ground and added and mixed with lubricant; finally, the Tacrolimus sustained release tablet is prepared after tabletting and drying. The sustained release tablet has the unique advantages of: reducing administration times, improving the administration adaptability of patients; after administration, having stable blood concentration, small toxic and side effects and improving the drug effect and safety; reducing the total dosage of drugs so as to achieve the greatest curative effect by the lowest dosage; being capable of being realized on most of tablet production lines and easily accepted by manufacturing units and manufacturers due to relatively simple preparation process; and having relatively low manufacturing cost and broad clinical application prospect.

The invention relates to a lotion formula which fulfills the aim of treating exogenous fever by traditional Chinese medicine washing therapy. The formula can achieve a satisfactory treatment effect on the exogenous fever by washing with a traditional Chinese medicine without injection or medicine taking, and solves the problem of injection pains and medicine-taking suffering, and particularly eliminates the harm of other oral medicines to human bodies. The traditional Chinese medicinal lotion is particularly suitable for infants who catch cold and have a fever, solves the problems of medicine-taking difficulty and injection pains of infants, and does not hurt tender entrails of the infants when treating diseases and abating fever.

The present invention provides a tamsulosin hydrochloride sustained-release capsule. The tamsulosin hydrochloride sustained-release capsule of the present invention can avoid the sudden release of the drug tablets and the performance differences generated from the gastric emptying differences, display minor food effect or do not display food effect, and obtain the stable curve of the plasma drug concentration and longer action time simultaneously, so as to reduce the occurrence of cardiovascular side effects, greatly improve the safety, effectiveness and compliance of the medication for the patients. The tamsulosin hydrochloride sustained-release capsule of the present invention can ensure the sustained and regular release of the main ingredient tamsulosin hydrochloride after the oral administration, and the present invention is characterized by convenient administration, durable function, stable efficacy, fewer side effects and so on.

The present invention is orally disintegrated nanometer lanthanum carbonate tablet and its preparation process. The orally disintegrated nanometer lanthanum carbonate tablet is prepared through one dry tabletting process, which includes the steps of drying the main medicine ingredient and supplementary material, including disintegrant, stuffing, effervescent, etc, sieving and tabletting; or one wet tabletting process, which includes the steps of mixing the main medicine ingredient and partial supplementary material, including disintegrant, stuffing, corrective, etc, sieving, drying, mixing with the other supplementary material and tabletting. The tabletting pressure is 2-15 MPa, and prepared orally disintegrated tablet has hardness of 2-5kg and extracorporeal disintegrating period of 20-80 sec. The orally disintegrated nanometer lanthanum carbonate tablet has high bioavailability, small dosage and high patient' s compliance.